To study the cytokine regulation of early stages of human Blymphopoiesis, we developed a stroma-free two-step culture system. Single human cord blood CD34
Introduction
Our understanding of the mechanisms that regulate the early stages of B-lymphopoiesis has been facilitated, especially in murine systems, by the development of culture assays that support the differentiation along B cell lineage of lymphohematopoietic progenitors that are capable of differentiation into both myeloid and lymphoid lineages. Cumano et al 1 developed a stromal-cell dependent culture assay in which bipotential progenitors enriched from the murine day-12 fetal liver differentiate along B cell and macrophage lineages in the presence of stromal cells and IL-7. Subsequently, they found that the stromal cells can be replaced by SCF (stem cell factor, also called c-kit ligand or steel factor) and IL-11. 2 Hirayama et al 3 developed a stromal cell-free two-step methylcellulose clonal culture assay in which murine multipotential lymphohematopoietic progenitors are allowed to differentiate into committed B cell progenitors and myeloid lineage cells. Using this culture assay, they demonstrated that combinations of SCF, flt3 ligand (FL), or IL-4 with IL-6, IL-11, G-CSF or IL-12 can support the generation of committed B cell progenitors from lymphohematopoietic progenitors, and that IL-1 and IL-3 inhibit this process. [4] [5] [6] [7] [8] Correspondence: F Hirayama, Hokkaido Red Cross Blood Center, Yamanote 2-2, Nishi-ku, Sapporo 063-0002, Japan; Fax: 81 11 613 4131 YY, FH and MK contributed equally to this work and should be regarded as cofirst authors Received 22 July 1999; accepted 19 November 1999 Similar culture systems have been established for human cells. For instance, Baum et al 9 established a coculture system in which human fetal bone marrow lymphohematopoietic progenitors are allowed to differentiate along B-lymphoid and myeloid lineages on cloned murine stromal cells. Rawlings et al 10, 11 recently developed a stromal cell-dependent culture assay in which CD34
+ or CD34 12 and we 13, 14 reported that the murine stromal cell line MS-5 can support the differentiation of individual single CD34
+ or CD34
− cord blood lymphohematopoietic progenitors to both CD19 + B cell progenitors and myeloid lineage cells. Using murine S17 stromal cell line, Hao et al 15 demonstrated the differentiation in culture of CD34 +
CD38
− cord blood progenitors along both myeloid and B-lymphoid lineages. However, all of these culture systems require stromal cells, and this stromal cell dependency has hampered the study of cytokine regulation of human early Blymphopoiesis from lymphohematopoietic progenitors. In this study, we established a stroma-cell free culture system and identified the cytokines that support the differentiation of primitive lymphohematopoietic progenitors toward B cell lineage. This stromal cell-free culture system should provide a strategy to study the cytokine regulation of human early lymphohematopoiesis and the mechanisms of the commitment to B cell lineage.
Materials and methods

Cytokines and cell lines
Recombinant human IL-3 and SCF were provided by Kirin Brewery (Tokyo, Japan). Recombinant human G-CSF and erythropoietin (Ep) were gifts from Chugai Pharmaceutical Co (Tokyo, Japan). Recombinant human IL-6 was provided by Ajinomoto (Kawasaki, Japan). Recombinant human FL was a gift from Immunex (Seattle, WA, USA). The concentrations of the cytokines were as follows: IL-3, 10 ng/ml; SCF, 10 ng/ml; G-CSF, 10 ng/ml; Ep, 2 U/ml; IL-6, 10 ng/ml; FL, 50 ng/ml. Murine stromal cell line, MS-5, was a gift from Dr KJ Mori (Niigata University, Niigata, Japan). Human B cell line, Nalm6, was provided by Dr A Muraguchi (Toyama Medical Pharmaceutical University, Toyama, Japan). MS-5 and Nalm6 were maintained in ␣-MEM (Gibco BRL, Gaithersburg, MD, USA) supplemented with 10% fetal calf serum (FCS, Hyclone, Logan, UT, USA).
Purification of progenitor cells
Cord blood was collected with informed consent after fullterm deliveries. Low density (Ͻ1.077 g/ml) mononuclear cells were collected with Ficoll-Paque (Pharmacia Biotech, 
CD38
− cells (100 to 150 cells/dish) were plated in methylcellulose medium in 35 mm suspension dishes. The culture mixture consisted of ␣-MEM, 1.0% 4000 cp methylcellulose, 30% FCS, 1% deionized Fraction V bovine serum albumin (BSA, Sigma Chemicals, St Louis, MO, USA), 50 M 2-mercaptoethanol (2-ME, Sigma) and a cocktail of growth factors including IL-3, IL-6, FL, SCF and G-CSF. Dishes were incubated at 37°C in a humidified atmosphere of 5% CO 2 /95% air for 14 days. The resulting primary colonies were individually harvested and recultured in secondary B-lymphoid culture to study their B-lymphoid potential. In some experiments, primary colonies growing in four dishes were pooled and aliquots of the cells were replated in secondary B-lymphoid culture. Secondary B-lymphoid culture was performed in 12-or 24-well plates. Aliquots of each primary colony were cultured on a monolayer of the murine stromal cell line MS-5 with ␣-MEM containing 10% FCS, SCF and G-CSF. The culture was maintained with a weekly half medium change. Three to 7 weeks later, non-adherent cells were collected by gentle pipetting and subjected to flow cytometric analysis.
Single cell culture
Enriched CD34
+
CD38
− cells were individually plated in 96-well multiwell plates by micromanipulation and cultured with IL-3, IL-6, FL, SCF, G-CSF and Ep. The resulting primary colonies were individually harvested on day 14 of culture. Thirty percent of the cells from each primary colony were recultured in secondary myeloid culture, and the rest of the cells was replated in secondary B-lymphoid culture to study myeloid and B-lymphoid potentials of the primary colonies, respectively. Secondary myeloid culture was carried out in 96-well multiwell plates with ␣-MEM containing 10% FCS, IL-3, IL-6, FL, SCF, G-CSF and Ep. After 6 days of culture, the cells were harvested and subjected to cytological examination. Secondary B-lymphoid culture was performed on MS-5 monolayers in 12-or 24-well plates.
Flow cytometric analysis
Non-adherent cells harvested from the secondary B-lymphoid culture were stained with fluorescein-conjugated antibodies and then analyzed using a flow cytometer (EPICS XL, Coulter). Antibodies used were FITC-rabbit anti-human IgM Ab (Dako Japan, Kyoto, Japan), FITC-anti-CD19 Ab (Dako Japan), PEanti-CD19 Ab (Dako Japan), and PE-anti-CD10 Ab (Dako Japan). Dead cells were gated out with forward vs side scatter window and propidium iodide staining. FITC-rabbit Ig, FITCIgG1, and PE-IgG1 were used as isotype controls.
Polymerase chain reaction (PCR) for Ig clonality
DNA was extracted with a QIAamp Blood Kit (Qiagen, Chatsworth, CA, USA) according to the manufacturer's protocol. A modified semi-nested PCR technique was used to amplify the CDR3 comprising the V-D-J region of the Ig heavy-chain gene. 16, 17 Briefly, for the first round of amplification, the framework 3 consensus primer (FR3A: 5Ј-ACACGGC [C/T][G/C]TGTATTACTGT-3Ј) and a downstream consensus primer directed at the joining region (LJH: 5Ј-TGAGGA GACGGTGACC-3Ј) were used. For the second round of PCR, the FR3A primer was used in conjunction with an inner downstream primer (VLJH: 5Ј-GTGACCAGGGTNCCTTGGCCC CAG-3Ј). In each round, the PCR mixture contained 10 mM Tris (pH 8.3), 50 mM KCl, 200 M each deoxynucleotide 5Ј-triphosphate (dNTP, Takara Biomedicals, Tokyo, Japan), 3 mM MgCl 2 and 2.5 units of Ampli-Taq Gold DNA polymerase (Perkin Elmer Cetus, Ueberlingen, Germany) in a 20 l total reaction mixture. The first-round PCR mixture contained 125 ng of DNA, and the second-round PCR contained 1 l of a 1 in 20 dilution of the first-round PCR product as a template. PCR amplification was performed as follows: activation of polymerase 95°C for 9 min, followed by 30 cycles of 95°C for 30 s, 50°C for 30 s, and 72°C for 30 s. PCR was terminated by a 10 min extension at 72°C. Use of the primers was expected to generate a fragment between 80 and 120 bp in length. The reaction products were analyzed on a 4% agarose gel.
Reverse transcription (RT)-PCR and Southern hybridization analyses for B cell specific gene expression
Enriched CD34
+ CD38 − cells were individually plated by micromanipulation in primary cultures supplemented with IL-3, IL-6, FL, SCF, G-CSF and Ep. The resulting primary colonies were individually harvested. Aliquots of 30% of the cells from each primary colony were recultured in secondary myeloid culture to study their myeloid potentials. The rest of the cells were pooled and examined for the expression of B cell lineage-specific genes by RT-PCR. Total RNA was extracted using TRIzol reagent (GIBCO BRL, Grand Island, NY, USA) according to the manufacturer's instructions. cDNA was prepared from total RNA, using 50 ng of random primers (GIBCO BRL), 200 M of each dNTP, and M-MLV reverse transcriptase (GIBCO BRL). Reverse-transcription products were then subjected to nested-PCR amplification. The first round of PCR was carried out using aliquots of cDNA samples, 75 ng/reaction of primers, and 1 U Ampli-Taq Gold DNA polymerase. The sequences of primers used for the first round PCR were as follows: 12, [18] [19] [20] Actin: sense, 5Ј-TGACGGGGTCACCCA-CACTGTGCCCATCTA-3Ј, and antisense, 5Ј-CTAGAA GCATTTGCGGTGGACGATGGAGGG-3Ј; CD10: sense, 5Ј-CTGTGACAATGATCGCACTCTATG-3Ј, and antisense, 5Ј-GA TTCCAGTTGCATTCATAGTAATCTC-3Ј; CD19: sense, 5Ј-TCA CCGTGGCAACCTGACCATG-3Ј, and antisense, 5Ј-GAG ACAGCACGTTCCCGTACTG-3Ј; Pax-5: sense, 5Ј-AGCA GGACAGGACATGGAGGA-3Ј, and antisense, 5Ј-ATCCT GTTGATGGAACTGACGC-3Ј; RAG-1: sense, 5Ј-GAGAGCA GAGAACACACTTT-3Ј; and antisense, 5Ј-CTTTTCAAAGG ATCTCACCC-3Ј; TdT: sense, 5Ј-CCTTGATGGCCTCCTCT CTCCTC-3Ј, and antisense, 5Ј-TCGGGGGGCCTGGGTT GGTGC-3Ј. The second round of PCR was carried out using 1 l of a 1 in 20 dilution of the first round PCR products as template. The sequences of primers used for the second round PCR were as follows: CD10: sense, 5Ј-GCTTGCGGA GGCTGGTTGAAACGT-3Ј, and antisense, 5Ј-GAGGTTCTC CACCTCTGCTATCAATAGCAG-3Ј; CD19: sense, 5Ј-ACCTG GAGATCACTGCTCGGCCAGTACTAT-3Ј, and antisense, 5Ј-GGGAGGCGTCACTTTGAAGAATCTC-3Ј; Pax-5: sense, 5Ј-GTGAATGGACGGCCACTCCCGGATG TAGTC-3Ј, and antisense, 5Ј-CCTGATCTCCCAGGCAAACATGGTGGGATT-3Ј; RAG-1: sense, 5Ј-GCAGACATCTCAACACTTTGGCC-3Ј, and antisense, 5Ј-GTGGGTGCTGAATTTCATCTGGGGCAGA-3Ј; TdT: sense, 5Ј-GGAACCACCCGCAGAGCGTTC CTCATGGAG-3Ј, and antisense, 5Ј-TAGTCTCTTCTCACAACAAGCTGG-3Ј. To ensure that PCR products were not derived from DNA, primers for the first round of PCR were defined from discrete exons for each transcript. PCR amplification was performed as follows: activation of polymerase 95°C for 9 min, followed by 30 cycles of 95°C for 1 min, 60°C for 2 min, 72°C for 2 min. PCR was terminated by a 10 min extension at 72°C. Aliquots from each PCR product were fractionated on 2.0% agarose gels, denatured in 0.5 M NaOH, neutralized in 0.5 M Tris-HCl (pH 7.5), and blotted on to Hybond-N+membranes (Amersham, Arlington Heights, IL, USA). Membranes were hybridized with digoxigenin (DIG)-conjugated oligonucleotide probes. The probes used were as follows; CD10: TCCCGAGACCAGCTCCCGTTACGGCAACTT, CD19: GAG-GACTGGTGGCTGGAAGGTCTCAGCTGT, Pax-5: ACATCTC CAGGCAGCTTCGGGTCAGCCATG, RAG-1: TGAGCAAGG TACCTCAGCCAGCATGGCAGC and TdT: CCTCGATGTCT CCTGGCTGATCGAATGCAT. The conjugation of oligonucleotide probes with DIG was carried out using a DIG oligonucleotide tailing kit (Boehringer Mannheim, Indianapolis, IN, USA). The hybridization was visualized using a DIG luminescent detection kit (Boehringer Mannheim).
Results
A cocktail of cytokines can maintain the B-lymphoid potential of CD34
+ progenitors
To established a stromal cell-free culture, we used cytokines that have been reported to have stimulating effects on primitive hematopoietic progenitors such as IL-3, 21,22 IL-6 23,24 and FL. 5, 25, 26 In addition, we utilized SCF and G-CSF, since these cytokines enhance stromal cell-dependent production of CD19 + B cell progenitors and CD19 − (150 cells/dish, four dishes/experiment) cells were plated in methylcellulose in the presence of IL-3, SCF, FL, IL-6 and G-CSF. The resulting primary colonies were picked up individually and recultured on monolayers of the murine stromal cell line MS-5 with SCF and G-CSF to examine their B-lymphoid potential. After 3-7 weeks of culture, non-adherent cells were harvested and analyzed for CD19
+ cells.
using a flow cytometer, no CD10 + nor CD19 + cells were found (data not shown). Therefore, to examine the B-lymphoid potential of the primary colonies, we recultured aliquots of each primary colonies on an MS-5 stroma cell monolayer with SCF and G-CSF. 13, 14 Of the 223 primary colonies, five (2.2%) produced CD19
+ B-lymphoid cells. These results suggested that the combination of IL-3, SCF, FL, IL-6 and G-CSF maintain the B-lymphoid potential of CD34 + progenitors for 14 days.
Enrichment for lymphohematopoietic progenitors
We then attempted to enrich the primitive progenitors that have B-lymphoid potential. 
CD38
− cells in three experiments, 74 (16%) yielded primary colonies on day 14 of culture. All the primary colonies eventually yielded macrophages, neutrophils and/or erythroblasts, when aliquots of each primary colony were individually recultured in secondary myeloid culture. The lineage expression of the progenitors is summarized in Table 3 . These results revealed that all primary colonies possessed myeloid potentials. When the rest of the cells of each primary colony were replated on a monolayer of MS-5 cells in the presence of SCF and G-CSF, 25 primary colonies (34%) produced CD19 + B-lymphoid cells after 2-4 weeks of secondary culture. Some of the CD19 + cells eventually differentiated into CD19 + sIgM + mature B cells after 4-7 weeks of secondary culture. Thus, these 25 progenitors proved capable of differen- 
− cells were plated individually by micromanipulation in methylcelullose in the presence of IL-3, SCF, FL, IL-6, G-CSF and Ep. The resulting primary colonies were picked up individually and divided into two portions. When a portion of each colony was recultured in secondary myeloid culture, all the colonies eventually differentiated to neutrophils, macrophages and/or erythroblasts. The rest of the cells were recultured with SCF and G-CSF on monolayers of the murine stromal cell line MS-5 to examine their B-lymphoid potential. After 3-7 weeks of culture, non-adherent cells were harvested and analyzed for CD19
+ cells. The results of three experiments are summarized here.
Table 3
Myeloid and B-lymphoid potentials of individual CD34 Of the total of 74 primary colonies presented in Table 2 , 25 gave rise to CD19 + cells in the secondary culture. Forty-nine generated no CD19 + cells. a Based on cytological examination of the cells from secondary myeloid culture. Abbreviations of lineage: m, macrophages; n, neutrophils; E, erythroblasts. Figure 2 . Of the 74 primary colonies, 59 (80%) were categorized as 'small colony' (total cell number was approximately less than 1000 under microscopic observation), and the rest were as 'large colony'. Although the small colonies were primarily composed of blast-like cells and the large colonies were composed of numbers of mature myeloid lineage cells in addition to blast-like cells, there were no remarkable differences between the small and the large primary colonies in myeloid potentials. In contrast, B cell potential was proved more frequently with the small colonies than with the large colonies (60% vs 27%). Experiments, in which CD34 
CD38
− single lymphohematopoietic progenitors carried out oligoclonal or polyclonal VDJ rearrangement of the immunoglobulin -chain gene.
Expression of B cell-specific transcripts by primary colonies
We next examined to what extent CD34 +
CD38
− lymphohematopoietic progenitors differentiated along B cell lineage in primary culture. Since CD10 + or CD19 + cells were not detected in primary colonies on flow cytometric analysis, we focused on mRNA expression of B cell-specific genes. We micromanipulated CD34 The sense primer FR3A corresponded to the highly conserved stretch near the 3Ј end of FR3 (codon 89 to 95). The anti-sense primers LJH and VLJH corresponded to sequences conserved among six J segments (codon 109 to 113 and 103 to 110, respectively). DNA was amplified using FR3A and LJH primers followed by FR3A and VLJH primers. cells to extract RNA for RT-PCR, we pooled primary colonies rather than examining each primary colony individually. Aliquots of each primary colony (10 to 22 primary colonies/experiment) were pooled, and RNA was extracted for RT-PCR and Southern hybridization analysis of B cell-specific transcripts such as CD10, CD19, Pax-5, RAG-1 and TdT. We performed four experiments, and in all the experiments CD10, CD19, Pax-5 and RAG-1 transcripts were positive, while TdT transcript was observed in only one experiment. The result of a representative experiment is shown in Figure 4a . We also assessed the lymphoid gene expression by fresh CD34 + CD38 − cells and found that CD19, Pax-5 and RAG-1 transcripts were all negative, whereas CD10 transcript was positive (Figure 4b ). Several possibilities may account for the expression of CD10 by CD34
One possibility is the contamination of CD10
+ cells in the original CD34 + CD38 − cell population. Another possibility is that the RT-PCR condition may have picked up some background expression of CD10. Alternatively, primitive lymphohematopoietic progenitors may express CD10 transcript as suggested by Gaffney et al. 28 Reculture of the rest of the cells of each primary colony in the secondary myeloid culture proved that all the primary colonies possessed myeloid potentials. These results suggested the differentiation of CD34 +
CD38
− lymphohematopoietic progenitors to committed B cell progenitors in the presence of IL-3, SCF, FL, IL-6 and G-CSF.
Role of individual cytokines
The precise role of the individual cytokines was first assessed by sequential deletion of single cytokine from the five cyto- 
CD38
− cells (100 cells/dish, four dishes) were plated in methylcelullose in the presence of designated cytokines. On day 14 of culture, after colony number was scored, all the colonies were picked up individually from the four dishes, pooled and calculated for total cell number. 10% of the pooled cells were recultured on monolayers of the murine stromal cell line MS-5 with SCF and G-CSF to examine their B-lymphoid potential. After 4 weeks of culture, non-adherent cells were harvested and analyzed for CD19 + cells. 3, IL-3; S, SCF; F, flt3 ligand; 6, IL-6; G, G-CSF.
kine cocktail (IL-3, SCF, FL, IL-6, G-CSF). As the result of a representative experiment of two is shown in Table 4 , Exp 1, omitting IL-3 or SCF greatly reduced primary colony formation especially in the number of total cells developed. In parallel, the ability of pooled primary colonies to produce CD19 + cells in the secondary lymphoid culture was also decreased, when IL-3 or SCF was omitted from the primary culture. These results indicated critical roles of IL-3 and SCF in the proliferation of CD34 + CD38
− primitive progenitors. Therefore, we next examined the effects of the combination of IL-3 and SCF with or without the addition of FL, G-CSF or IL-6. The twocytokine combination, IL-3 plus SCF supported the growth of only less than one-tenth as many primary colony cells as compared to the five-cytokine combination. The addition of FL, G-CSF or IL-6 to the two-cytokine combination significantly restored the proliferation of the cells in primary culture. Although the magnitude of the restoration varied among the four experiments we performed, FL was more effective than G-CSF and IL-6 in all the experiments. The results of a representative experiment are presented in Table 3 , Exp 2. In addition, the reduced production of CD19
+ cells by the primary colonies developed in the presence of IL-3 and SCF was greatly enhanced by the addition of FL, G-CSF or IL-6 in the primary culture. These results suggested that (1) IL-3, SCF and FL can efficiently support the proliferation of CD34 + CD38 − primitive progenitors and G-CSF and IL-6 may have similar activity as FL, although not as effective as FL; and (2) the three cytokine combinations, SCF, IL-3 and either of FL, G-CSF or IL-6, can support the B cell capability within the primary colonies. However, the differentiation stage of B cell progenitors developed in primary culture could be different when different combinations of cytokines are utilized, and hence their proliferation and differentiation capacity in the secondary B cell culture could also be different. Therefore, the number of CD19 + cells produced in the secondary B cell culture may not directly reflect that of B cell progenitors developed in primary colonies. In order to clarify the minimum requirement of cytokines for the development of B cell progenitors, further studies need to be performed.
Discussion
In this study we established a stromal cell-free culture system and showed that the combination of IL-3, SCF, FL, IL-6 and G-CSF can support the differentiation of CD34 
CD38
− lymphohematopoietic progenitors differentiated toward B cell lineage in culture. Although the expression of the B cell transcripts suggested the commitment of primitive progenitors to B cell lineage, it is not certain at this time whether it is the case. It remains to be clarified.
To gain insight into the contributing cytokines, we carried out a brief survey of combinations of the five cytokines and found that three cytokines, IL-3, SCF and FL, can support the efficient proliferation of CD34 +
− primitive progenitors and their differentiation toward B cell lineage. We also dem-onstrated that G-CSF and IL-6 could replace FL. Critical roles of SCF and FL in early B-lymphopoiesis has recently been reported. 29 Our results are in agreement with it. In contrast, it has been demonstrated that IL-3 has strong inhibitory effects in the early stage of B-lymphopoiesis in vitro 7, 8, 30 and in vivo 31 in the murine system. The addition of IL-3 in culture also suppresses the T 32 and NK cell 33 potentials of primitive progenitors and abrogates reconstituting abilities of stem cells. 30, 34 These observations suggested that clinical use of IL-3 may need to be carefully monitored for preservation of lymphohematopoietic progenitors. However, in our current study, the addition of IL-3 in primary culture did not inhibit the Blymphoid potential of CD34
− lymphohematopoietic progenitors. This result may suggest that the effects of IL-3 on human lymphohematopoiesis are different from those on murine lymphohematopoiesis. This issue is important in the field of ex vivo stem cell expansion and needs to be elucidated in future.
Transcripts of all the B cell-specific genes examined except TdT were detected in all the four experiments, while TdT mRNA was observed in only one experiment. Considering that only limited number (10 to 22) of primary colonies were pooled in each experiment to examine mRNA expression, it is likely that the frequency of the primary colonies that contained TdT + cells was lower than that of the primary colonies positive for the other B cell-specific transcripts. Therefore, we speculate that the CD19 + Pax-5 + RAG-1 + stage precedes the TdT + stage. In contrast, Ryan et al 35, 36 have reported that TdT is expressed by CD34 + CD19 − early lymphoid progenitors before CD19 is expressed. The reasons for the differences between their results and ours are not yet known, but it is possible that TdT has been downregulated in the cells after an initial period of expression. It could also be that in vivo and in vitro differentiation pathways are different.
The extensive proliferation of CD10 + and CD19 + cells and their differentiation to mature IgM + B cells were observed only when primary colonies were recultured in secondary Blymphoid culture on an MS-5 stromal cell monolayer with SCF and G-CSF. 13 MS-5 cells are reported to produce IL-7 37 and pre-B cell growth-stimulating factor (PBSF). 38 Namikawa et al 39 reported that IL-7 supports the differentiation and proliferation of CD34 − immature progenitors. Nagasawa et al 40, 41 demonstrated that PBSF plays an important role in murine B-lymphopoiesis in vitro and in vivo. Therefore, these cytokines are excellent candidates for the key factors in the late stage of Blymphopoiesis. As to when VDJ rearrangement starts, we have no direct answer at this time. Since VDJ rearrangement was not detected in pooled primary colonies (data not shown), it is likely that VDJ rearrangement occurs only in the secondary B cell culture. Tagoh et al 19, 42 recently reported that a cognate interaction between human lymphoid progenitors and stromal cells is required for RAG-1 activation and that the interaction is mediated through a protein which is expressed by stromal cells and belongs to the tetra-span transmembrane protein family. Such signals mediated by cell-cell contact between B cell progenitors and MS-5 cells could be essential to VDJ rearrangement of immunoglobulin genes in our secondary B cell culture. Considering the low frequency of CD10 + , CD19 + cells in primary colonies, however, we cannot exclude the possibility that a small number of B cell progenitors already started VDJ rearrangement in the primary culture and extensively expanded in the secondary B cell culture.
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